L. Vacirca - Aug 31, 2022 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC (SPPI)

Role
Director
Signature
/s/ Keith M. McGahan, attorney-in-fact for Jeffrey L. Vacirca
Stock symbol
SPPI
Transactions as of
Aug 31, 2022
Transactions value $
$0
Form type
4
Date filed
9/2/2022, 04:49 PM
Previous filing
Feb 14, 2022
Next filing
Oct 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +25K +14.68% $0.00 195K Aug 31, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPPI Stock Option (Right to Buy) Award $0 +75K $0.00 75K Aug 31, 2022 Common Stock 75K $1.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted on August 31, 2022. One hundred percent (100%) of the total number of RSUs granted vest on the earlier of (i) June 22, 2023 or (ii) the date of the Company's 2023 Annual Meeting of Stockholders.
F2 One third of the aggregate amount of option shares shall vest on each of August 31, 2023, 2024 and 2025, respectively.